KR100194524B1 - Antifungal Toilet Soap Composition - Google Patents
Antifungal Toilet Soap Composition Download PDFInfo
- Publication number
- KR100194524B1 KR100194524B1 KR1019960061013A KR19960061013A KR100194524B1 KR 100194524 B1 KR100194524 B1 KR 100194524B1 KR 1019960061013 A KR1019960061013 A KR 1019960061013A KR 19960061013 A KR19960061013 A KR 19960061013A KR 100194524 B1 KR100194524 B1 KR 100194524B1
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic soap
- weight
- antifungal
- foot
- soap composition
- Prior art date
Links
- 239000000344 soap Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 229940121375 antifungal agent Drugs 0.000 title claims abstract description 20
- 230000000843 anti-fungal effect Effects 0.000 title abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 29
- 239000003429 antifungal agent Substances 0.000 claims abstract description 15
- 238000004299 exfoliation Methods 0.000 claims abstract description 14
- 239000003002 pH adjusting agent Substances 0.000 claims abstract description 12
- 108010076876 Keratins Proteins 0.000 claims abstract description 11
- 102000011782 Keratins Human genes 0.000 claims abstract description 11
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000004308 thiabendazole Substances 0.000 claims abstract description 3
- 235000010296 thiabendazole Nutrition 0.000 claims abstract description 3
- 229960004546 thiabendazole Drugs 0.000 claims abstract description 3
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 12
- 229930195729 fatty acid Natural products 0.000 claims description 12
- 239000000194 fatty acid Substances 0.000 claims description 12
- 150000004665 fatty acids Chemical class 0.000 claims description 12
- 235000019482 Palm oil Nutrition 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 8
- 239000002540 palm oil Substances 0.000 claims description 8
- 150000001447 alkali salts Chemical class 0.000 claims description 6
- 230000000774 hypoallergenic effect Effects 0.000 claims description 5
- 239000012459 cleaning agent Substances 0.000 claims description 4
- 229940099451 3-iodo-2-propynylbutylcarbamate Drugs 0.000 claims description 3
- WYVVKGNFXHOCQV-UHFFFAOYSA-N 3-iodoprop-2-yn-1-yl butylcarbamate Chemical compound CCCCNC(=O)OCC#CI WYVVKGNFXHOCQV-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 235000021323 fish oil Nutrition 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 239000003346 palm kernel oil Substances 0.000 claims description 3
- 235000019865 palm kernel oil Nutrition 0.000 claims description 3
- 239000003760 tallow Substances 0.000 claims description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 3
- 235000019871 vegetable fat Nutrition 0.000 claims description 3
- 239000004902 Softening Agent Substances 0.000 claims description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 claims description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 claims 1
- 150000001280 alpha hydroxy acids Chemical group 0.000 claims 1
- BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 abstract description 21
- 201000004647 tinea pedis Diseases 0.000 abstract description 21
- 239000004480 active ingredient Substances 0.000 abstract description 2
- MFQARMSJVKMVMG-UHFFFAOYSA-M C(#CC)N(C([O-])=O)CCCC.[I+] Chemical compound C(#CC)N(C([O-])=O)CCCC.[I+] MFQARMSJVKMVMG-UHFFFAOYSA-M 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 6
- 210000003491 skin Anatomy 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 229940120503 dihydroxyacetone Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- -1 acyl isethionic acid Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 159000000011 group IA salts Chemical class 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000019645 odor Nutrition 0.000 description 2
- 238000001139 pH measurement Methods 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940079776 sodium cocoyl isethionate Drugs 0.000 description 2
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 101000998023 Acipenser baerii Keratin, type I cytoskeletal 18 Proteins 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241001480035 Epidermophyton Species 0.000 description 1
- 241001480036 Epidermophyton floccosum Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 125000002252 acyl group Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N beta-hydroxyethanesulfonic acid Natural products OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000008149 soap solution Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000152 swallowing effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Landscapes
- Detergent Compositions (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 화장비누 세정기제에 요오드프로피닐부틸카르바메이트, 티아벤다졸 및 헥사아미딘디이세치오네이트중에서 선택된 1종 또는 2종 이상의 항진균제, 각질 박리/연화제 및 pH 조정제를 함유함으로써, 조성물의 액성이 피부의 pH와 유사한 약산성이며, 약효성분의 안정성을 지속적으로 유지하고, 인체에 안전하게 무좀을 예방하거나 치료효과를 나타내는 항진균성 화장비누 조성물에 관한 것이다.The present invention relates to the preparation of a composition by containing one or two or more antifungal agents selected from iodine propynylbutylcarbamate, thiabendazole and hexaamidine diethionate, keratin exfoliation / softener and pH adjusting agent in a cosmetic soap cleaner. It relates to an antifungal cosmetic soap composition which has a weak acidity similar to the pH of the skin, maintains the stability of the active ingredient, and safely prevents or treats athlete's foot.
Description
[발명의 명칭][Name of invention]
항진균성 화장비누 조성물Antifungal Toilet Soap Composition
[발명의 상세한 설명]Detailed description of the invention
[발명의 목적][Purpose of invention]
본 발명은 통상적인 화장비누의 사용 방법으로 무좀의 예방 및 치료 효과를 가지는 항진균성 화장비누 조성물에 관한 것이다. 더욱 상세히 설명하면, 본 발명은 저작극 세정성분과 고급지방산의 약알칼리염을 혼합 사용하는 화장비누의 세정기제에 항진균제, 각질 박리/연화제 및 pH 조정제를 함유하고, 그이 액성이 피부의 pH와 유사한 약산성으로서, 약효성분의 안정성을 지속적으로 유지하고, 인체에 안전하게 무좀을 예방하거나 치료효과를 나타내는 항진균성 화장비누 조성물에 관한 것이다.The present invention relates to an antifungal cosmetic soap composition having a prophylactic and therapeutic effect of athlete's foot by using a conventional cosmetic soap. In more detail, the present invention comprises an antifungal agent, a keratin peeling / softening agent and a pH adjusting agent in the cleaning base of the cosmetic soap using a mixture of the mastication cleaning component and a weak alkaline salt of higher fatty acids, the liquidity of which is similar to the pH of the skin As weakly acidic, the present invention relates to an antifungal cosmetic soap composition that continuously maintains the stability of an active ingredient and safely prevents or treats athlete's foot.
[발명이 속하는 기술분야 및 그 분야의 종래기술][Technical field to which the invention belongs and the prior art in that field]
일반적으로, 무좀균은 인체의 발과 같은 습하고, 따듯하며, 불결한 곳에서 번식하는 곰팡이균의 일종으로, 피부이 각질층에 침투하여 인설, 균열, 악취 및 가려움증을 유발시키고, 이로 인해 상처를 일으키는 고질적인 특성을 가지고 있다.In general, Athlete's foot is a kind of fungus that grows in moist, warm, and dirty places such as the human foot, and the skin penetrates the stratum corneum, causing sebum, cracks, odors and itching, and thereby causing a wound. Have
이와 같은 무좀의 종류는 여러가지가 있으나, 무좀의 발생 부위 및 형태에 따라 크게 3가지로 분류하고 있다. 지간형은 무좀의 가장 흔한 형태로서 제3, 4 지간에서 잘 발생되며, 균열, 냄새 및 심한 소양감을 나타낸다. 소수포형은 발바닥 및 그의 주변부에 작은 수포들이 잔재하고, 수포 형성시에 가려움증이 심한 것이 특징적이다. 또한, 각화형은 발바닥이 각화되어, 건조하게 되고, 균열이 일어나는 만성적인 난치형이다. 이러한 무좀을 발생시키는 대표적인 무좀균들은 트리코파이톤멘타그로파이트(T. Mentagrophytes), 트리코파이톤 루브룸(T. Rubrum), 에피더모파이톤 플로코좀(E. Floccosum) 등으로 알려지고 있으며, 대체적으로 피부에 침투하여 번식하기 때문에 무좀을 완치하기는 쉽지 않다.There are many kinds of such athlete's foot, but are classified into three types according to the generation site and type of athlete's foot. Bones are the most common form of athlete's foot and occur well in the 3rd and 4th zones, and show cracks, odors and severe pruritus. The hydrophobic form is characterized by small blisters remaining on the sole and its periphery and severe itching at blister formation. In addition, the keratin type is a chronic refractory type in which the sole of the foot is angled, dried, and cracks occur. Representative athlete's foot causing bacteria are known as T. Mentagrophytes, T. Rubrum, and Epidermophyton Flocosum (E. Floccosum), generally penetrating the skin It is not easy to cure athlete's foot because it breeds.
무좀 치료를 위해 구전으로 전래되는 민간요법으로는 식초를 적당량 섞은 물에 발을 장시간 담구어 무좀을 치료하는 방법이 알려져 있으나, 일정한 농도 조절이 쉽지 않기 때문에, 농도가 높을 경우, 발에 화상을 입을 수 있으며, 이로 인해 다른 합병증을 유발시킬 수 있는 위험이 있다. 또한, 액상이나 크림상의 무좀 치료제가 많이 있으나, 약물 투여 방법의 불편함 및 치료 효과에 대한 한시성에 의해 치료를 중단하게 됨으로서, 무좀이 쉽게 재발하게 되고, 완치가 어렵게 된다. 또한, 무좀 환자들은 일반 화장비누로 발을 세정할 경우 무좀이 더욱 악화된다는 이유로 화장비누 사용을 기피하는 경향이 있다. 이는 화장비누 수용액의 액성이 약알칼리성이기 때문에 비누 사용시, 약산성인 피부의 pH가 순간적으로 상승하였다가, 자체의 애시드 맨틀 메인터넌스(Acid Mentle Maintanance)에 의해 원래의 pH로 복원하게 되는데, 이때 무좀균들의 활동이 활발해지기 때문인 것으로 알려지고 있다.Folk remedies that are orally transmitted for treating athlete's foot are known to treat athlete's foot by soaking feet in water mixed with vinegar for a long time, but it is not easy to control the concentration, so if the concentration is high, the foot may be burned. There is a risk that this can lead to other complications. In addition, there are a lot of liquid or creamy athlete's foot treatment, but by stopping the treatment due to the discomfort of the drug administration method and the time limit for the therapeutic effect, the athlete's foot recurs easily, it is difficult to cure. In addition, athletes with athlete's foot tend to avoid using cosmetic soap because the athlete's foot is worsened when regular foot soap is used. Since the liquidity of the aqueous soap solution is weakly alkaline, when using soap, the pH of the slightly acidic skin instantly rises, and is restored to its original pH by its acid mentle maintenance. This is known to be active.
[발명이 이루고자 하는 기술적 과제][Technical problem to be achieved]
따라서, 본 발명자들은 상술한 바와 같이 무좀과 관련된 특징을 예의 연구한 결과, 각질층에 침투하는 무좀균의 지속적이고 효과적인 치료는 각질층을 박리/연화시키고, 무좀균을 살균할 수 있는 항진균제의 복합 처방을 약산성의 화장비누 세정기제에 기술적으로 응용하면, 일상적으로 사용하는 화장비누로서 청결한 발 상태를 유지하고, 무좀균의 지속적인 살균에 의해 무좀을 예방하거나 완치할 수 있다는 놀라운 사실을 밝혀내고 본 발명을 완성하게 되었다.Therefore, the present inventors have studied the characteristics related to athlete's foot as described above. As a result, the continuous and effective treatment of athlete's foot penetrating the stratum corneum is a weakly acidic combination of antifungal agents that can exfoliate / soften the stratum corneum and sterilize the athlete's foot. Technically applied to the cosmetic soap cleaning agent, the present invention was completed by remarking the surprising fact that it is possible to maintain a clean foot state as a daily use of cosmetic soap and to prevent or cure athlete's foot by continuous sterilization of athlete's foot.
[발명의 구성 및 작용][Configuration and Function of Invention]
본 발명은 화장비누의 세정기제에 0.1 내지 5.0 중량%의 항진균제, 4.0 내지 30.0 중량%의 각질 박리/연화제 및 0.1 내지 6.0 중량%의 pH 조정제를 함유함을 특징으로 하는 화장비누 조성물에 관한 것이다.The present invention relates to a cosmetic soap composition characterized in that it contains 0.1 to 5.0% by weight of antifungal agent, 4.0 to 30.0% by weight of keratin exfoliation / softener and 0.1 to 6.0% by weight of pH adjuster.
본 발명을 상세히 설명하면 다음과 같다.The present invention is described in detail as follows.
본 발명에서 화장비누 세정기제는 저자극 세정성분을 단독으로 또는 저자극 세정성분과 고급지방산의 약알칼리염을 혼합사용한다. 저자극 세정성분은 아실이세치온산, 아실설포석신산, 아실사코신산, 아실알킬타우린산 및 아실글루타민산의 알칼리 염(여기서, 알칼리 염은 나트륨, 칼륨 또는 트리에탄올아민임)을 1종 또는 2종 이상 혼합 사용할 수 있지만, 본 발명이 실시예 및 비교예에서는 소디움코코일이세치오네이트를 사용한다.In the present invention, the cosmetic soap cleaning agent may be used alone or a mixture of the mild alkaline salt of the mild fatty acid and the hypoallergenic cleaning component. The hypoallergenic cleaning component includes one or two or more alkali salts of acyl isethionic acid, acyl sulfosuccinic acid, acyl sacosuccinic acid, acylalkyltauric acid and acyl glutamic acid, wherein the alkali salts are sodium, potassium or triethanolamine. Although mixed may be used, sodium cocoyl isethionate is used in the examples and comparative examples of the present invention.
본 발명에서 사용한 고급지방산의 약알칼리염은 우지, 돈지, 어유, 팜유, 야자유, 팜핵유 등의 동식물 유지로부터 유도되는 탄소수 8 내지 탄소수 20 이하의 고급 지방산과 나트륨, 칼륨, 트리에탄올아민의 산 알칼리 중화반응으로 얻어지는 약알칼리염이 있지만 본 발명의 실시예 및 비교예에서는 소디움스테아레이트를 사용한다.The weak alkali salts of higher fatty acids used in the present invention are acid alkali neutralization of higher fatty acids having 8 to 20 carbon atoms and higher sodium and potassium, triethanolamine derived from animal and vegetable fats and oils such as tallow, lard, fish oil, palm oil, palm oil and palm kernel oil. Although there is a weak alkali salt obtained by the reaction, sodium stearate is used in Examples and Comparative Examples of the present invention.
본 발명의 화장비누 조성물에서 항진균제는 요오도프로피닐부틸카르바메이트(iodopropynylbutylcarbamate), 티아벤다졸(thiabendazole), 헥사아미딘 디이세치오네이트(hexamidine diisethionate)중에서 선택된 1종 또는 2종 이상을 혼합하여 사용한다. 본 발명에 사용되는 항진균제는 항진균 효과가 매우 우수하며, 상기 3종의 항진균 효과는 서로 유사하게 나타났다. 본 발명의 화장비누 조성물에서 항진균제는 0.1 내지 5.0 중량% 사용하는 것이 바람직하다. 항진균제를 0.1 중량% 미만을 사용할 경우에는 비누의 항진균 효과가 거의 없으며, 5.0 중량%를 초과 사용할 경우에는 항진균 효과는 우수하지만 비누의 경시안정성이 나빠져서 비누의 초기의 색상이 갈색으로 변하게 된다.Antifungal agent in the cosmetic soap composition of the present invention by mixing one or two or more selected from iodopropynylbutylcarbamate, thiabendazole, hexamidine diisethionate use. The antifungal agent used in the present invention has an excellent antifungal effect, and the three antifungal effects were similar to each other. The antifungal agent in the cosmetic soap composition of the present invention is preferably used 0.1 to 5.0% by weight. If the antifungal agent is used less than 0.1% by weight, there is almost no antifungal effect of the soap, when the antifungal agent is used more than 5.0% by weight, the antifungal effect is excellent, but the time-lapse stability of the soap worsens, so the initial color of the soap turns brown.
본 발명의 화장비누 조성물에서 각질 박리/연화제는 우지, 돈지, 어유, 팜유, 야자유, 팜핵유 등의 동식물 유지로부터 유도되는 탄소수 8 내지 탄소수 20 이하의 고급지방산으로서, 이들은 1종 또는 2종 이상을 혼합하여 사용할 수 있다. 본 발명에서 각질 박리/연화제는 4.0 내지 30.0 중량% 함유하는 것이 바람직하다. 각질 박리/연화제를 4.0 중량% 미만 사용할 경우에는 각질 박리/연화 효과가 충분히 나타나지 않으며, 30.0 중량%를 초과 사용할 경우에는 비누 제조시 비누가 무르고, 끈적거려 성형, 압출 및 형타가 어려워 화장비누를 제조할 수 없게 된다. 본 발명의 실시예 및 비교예에서는 라우릭산 및 야자유지방산을 단독 또는 혼합하여 사용하였다.In the cosmetic soap composition of the present invention, the keratin exfoliation / softener is a higher fatty acid having 8 to 20 carbon atoms or less derived from animal or vegetable fats and oils such as tallow, lard, fish oil, palm oil, palm oil, palm kernel oil, and the like. It can be mixed and used. In the present invention, the keratin exfoliation / softener is preferably contained in the range of 4.0 to 30.0% by weight. If less than 4.0% by weight of keratin exfoliation / softener is used, the exfoliation / softening effect is not sufficiently exhibited. If it is used more than 30.0% by weight, soap is soft, sticky, difficult to mold, extruded and molded to prepare soap. You will not be able to. In Examples and Comparative Examples of the present invention, lauric acid and palm oil fatty acid were used alone or in combination.
본 발명에서 pH 조정제는 글리콜릭산, 락틱산, 말릭산, 타르타릭산, 시트릭산, 글루코닉산 등이 알파하이드록시 산류 및 살리실릭산, 세린 등의 베타 하이드록시산류를 1종 또는 2종 이상을 혼합 사용할 수 있다. 본 발명에서 pH 조정제는 0.1 내지 6.0 중량% 함유하는 것이 바람직하다. pH 조정제는 사용되는 산의 종류에 따라 약간의 pH 차이가 있지만 0.1 중량% 미만 사용할 경우에는 본 조성물의 pH가 7.0을 초과하게 되며, 6.0 중량%를 초과하여 사용할 경우에는 본 조성물의 pH가 5.5미만으로 나타나게 되고, 이로인해 본 조성물의 경시 색상 안정성이 나쁘게 되는데, 이는 pH 조정제의 과량 사용에 의해 세정성분들이 가수분해되어 나타나는 현상으로 추정된다.In the present invention, the pH adjusting agent is one or two or more of glycolic acid, lactic acid, malic acid, tartaric acid, citric acid, gluconic acid, and the like, or one or two or more beta hydroxy acids such as salicylic acid and serine. Can be used mixed. In the present invention, the pH adjuster preferably contains 0.1 to 6.0% by weight. The pH adjuster has a slight pH difference depending on the type of acid used, but when used below 0.1% by weight, the pH of the composition is greater than 7.0, and when used above 6.0% by weight, the pH of the composition is less than 5.5. This results in poor color stability of the composition over time, which is presumed to be a phenomenon in which the cleaning components are hydrolyzed by the excessive use of the pH adjuster.
그외에 본 발명의 화장비누 조성물에서는 결합제로성 유기염 및 무기염을 사용할 수 있으며 또한 유화제, 향료, 색소, 금속이온봉쇄제 및 산화방지제를 혼합하여 사용할 수도 있다.In addition, the cosmetic soap composition of the present invention can be used as a binder organic salts and inorganic salts, and may also be used in combination with an emulsifier, a flavoring agent, a pigment, a metal ion blocking agent and an antioxidant.
본 발명의 화장비누 조성물은 일반적인 화장비누의 제조 방법에 따라 제조할 수 있다. 먼저 아말감메이터에서 저자극 세정성분, 고급 지방산의 약알칼리염 및 기타 첨가제를 교반 혼합하고, 여기에 항진균제와 pH 조정제를 각질 박리/연화제에 분산 용해시킨 것을 서서히 첨가하여 (필요시 소량의 물과 유화제를 사용할 수 있음), 조성물들이 균일하게 혼합될 수 있도록 로울밀을 통과시킨 후, 이를 성형, 압출, 절단 및 형타하여 일정한 모양의 화장비누 조성물을 제조한다.The cosmetic soap composition of the present invention can be prepared according to a general method of manufacturing cosmetic soap. First, in the amalgamator, stir-mix the hypoallergenic cleaning component, the weak alkali salt of higher fatty acid, and other additives, and slowly add the dissolve and dissolve the antifungal agent and the pH adjuster in the keratin exfoliation / softener (if necessary, a small amount of water and emulsifier) May be used), and then passed through a roll mill so that the compositions may be uniformly mixed, and then molded, extruded, cut and shaped to prepare a cosmetic soap composition having a uniform shape.
이하, 본 발명을 시시예 및 비교예에 의해 더욱 상세히 설명하지만, 본 발명의 기술적 범위가 이들로 제한되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Comparative Examples, but the technical scope of the present invention is not limited thereto.
[실시예 1]Example 1
53.0 중량%의 소디움코코일이세치오네이트, 7.0 중량%의 소디움스테아레이트, 9.2 중량%의 정제수, 0.3 중량%의 이산화티탄 및 1.0 중량%의 향료를 아말감메이터에 넣고 서서히 혼합 교반시키면서, 여기에 0.5 중량%의 요오도프로피닐부틸카르바메이트와 3.5 중량%의 글리콜릭산을 20.5 중량%의 야자유지방산과 5.0 중량%의 라우릭산에 분산 용해시켜 첨가하고, 로울밀로 균일하게 혼합하여, 이를 성형, 압출, 절단 및 형타하여 일정한 모양의 화장비누 조성물을 제조하였다.53.0% by weight of sodium cocoyl isethionate, 7.0% by weight of sodium stearate, 9.2% by weight of purified water, 0.3% by weight of titanium dioxide, and 1.0% by weight of perfume are placed in an amalgamator and slowly mixed and stirred therein. 0.5% by weight of iodopropynylbutylcarbamate and 3.5% by weight of glycolic acid are added by dispersing and dissolving in 20.5% by weight of palm oil fatty acid and 5.0% by weight of lauric acid, and uniformly mixed with a roll mill to form, Extruded, cut and molded to prepare a cosmetic soap composition of a uniform shape.
[실시예 2-6 및 비교예 1-5]Example 2-6 and Comparative Example 1-5
실시예 2-3 및 비교예 1-5는 다음 표1에 나타낸 성분 및 함량에 따라 실시예 1과 동일한 화장 방법으로 비누를 제조한다.Example 2-3 and Comparative Example 1-5 are prepared by the same cosmetic method as in Example 1 according to the ingredients and contents shown in Table 1 below.
실험방법Experiment method
상기과 같이 제조한 실시예 1-6 및 비교예 1-5의 화장비누 조성물을 다음의 실험방법에 따라 각질 박리/연하 효과, 항진균효과, 작업성, 경시안정성 및 pH를 측정하였다.The cosmetic soap compositions of Example 1-6 and Comparative Example 1-5 prepared as described above were measured for the exfoliation / swallowing effect, antifungal effect, workability, time stability and pH according to the following experimental method.
1) 각질 박리/연화 효과1) keratin exfoliation / softening effect
본 발명에서의 각질 박리/연화 효과는 성인 15명을 대상으로 10%의 디하이드록시아세톤용액 0.4㎖를 힐탑 챔버에 넣고, 팔의 상부 안쪽 부위에 1시간동안 부착시킨후, 이를 제거하고, 착색 정도를 높이기 위하여 6시간 경과후 디하이드록시아세톤 용액을 반복 처리한다. 24시간 경과후, 색차계로 디하이드록시아세톤용액 처리 전후를 측정한다. 8% 수용액의 시료를 도포하면서 매일 색상변화를 △E값으로 측정하여 탈색 정도가 초기 피부와 같게 될 때를 각질 박리/연화 효과로 간주한다. 각질 박리/연화 효과는 수치가 낮을수록 효과가 좋은 것을 의미하며, △E값은 색차계로 측정된 L, a, b 값을 다음식에 의해 산출한다.In the present invention, keratin exfoliation / softening effect was put into a hilltop chamber with 0.4 ml of 10% dihydroxyacetone solution for 15 adults and attached to the upper inner part of the arm for 1 hour, and then removed and colored. After 6 hours, the dihydroxyacetone solution is repeatedly treated to increase the degree. After 24 hours, the dihydroxy acetone solution is measured before and after the color difference meter. The color change is measured by ΔE value every day while applying a sample of 8% aqueous solution, and when the degree of discoloration becomes the same as the initial skin, it is regarded as the exfoliation / softening effect. The keratin exfoliation / softening effect means that the lower the numerical value, the better the effect. The ΔE value calculates the L, a, and b values measured by the color difference meter by the following equation.
△E = 『 (△L) + (△a)+ (△b) } 여기서 n = 1/2ΔE = `` (△ L) + (Δa) + (Δb) } Where n = 1/2
2) 항진균 효과2) antifungal effect
항진균효과는 각 시료를 농도별로 희석하여 각각의 무좀균에 접종하는 희석고체 평판 배지 배양법에 따라 각 균의 최소 성장 억제 농도(M.I.C)를 측정하였으며, 수치가 작을수록 항진균효과가 우수한 것이다. 본 발명에 사용할 수 있는 항진균제 자체에 대한 균의 최소 성장 억제 농도 측정 결과는 다음과 같이 나타났다. 각 항진균제에 대한 균의 최소 성장 억제 농도는 서로 비슷하며, 또한 이의 항진균 효과는 매우 우수한 수준이다.Antifungal effect was determined by diluting each sample by concentration and inoculating each athlete's foot fungus by diluting solid plate culture medium. The minimum growth inhibitory concentration (M.I.C) of each bacterium was measured. The smaller the value, the better the antifungal effect. As a result of measuring the minimum growth inhibitory concentration of the bacteria against the antifungal agent itself that can be used in the present invention was shown as follows. The minimum growth inhibitory concentration of the bacteria for each antifungal agent is similar to each other, and its antifungal effect is very good.
작업성은 일반 지방산계 화장비누의 제조 공정으로 비누를 제조할 때 성형, 압출 및 형타 상태에서 비누가 기계에 달라붙고 끈적거리는 이형성 상태를 다음 기준으로 평가한다.The workability is evaluated based on the following criteria when the soap is stuck to the machine in the molding, extrusion and mold state when the soap is manufactured by the manufacturing process of the general fatty acid cosmetic soap.
4) 경시 안정성4) Stability over time
각 시료를 상온 및 40℃의 향온항습기에 3개월 동안 보관시키고, 1주일 간격으로 시료의 생상변화를 상온 보관 시료와 육안으로 비교 판정한다.Each sample is stored for 3 months in a room temperature and 40 ° C humidity chamber, and the raw material change of the sample is visually compared with the stored sample at a weekly interval.
5) pH측정5) pH measurement
pH측정은 시료의 1% 수용액을 pH이온 미터로 측정하였다. 또한, 실시예 1에 대한 글리콜릭산과 시트릭산의 함량별 pH 변화 결과는 다음과 같이 나타났다.In pH measurement, 1% aqueous solution of the sample was measured with a pH ion meter. In addition, the pH change results according to the content of glycolic acid and citric acid for Example 1 were as follows.
상기 시험결과는 하기 표 2에 나타내었다.The test results are shown in Table 2 below.
상기표 2의 실험결과로부터 알 수 있는 바와 같이, 항진균 효과에 있어서 균의 최소 성장 억제 농도는 항진균제의 사용량에 따라 약간씩 차이가 나타나고 있으며, 비누 사용 농도 및 균의 최소 살균 농도를 고려할 경우, 실험 결과와 같이 본 발명의 항진균제는 0.1 중량% 이상 사용하여야 하며, 또한 경시 안정성이 나빠지기 때문에 5 중량%를 초과하지 않아야 한다. 무좀환자 20명을 대상으로 실시예 1의 화장비누 조성물을 1개월간 임상 실험한 결과 약 75%의 치유율을 나타냈다.As can be seen from the experimental results of Table 2, the minimum growth inhibitory concentration of the bacteria in the antifungal effect is slightly different depending on the amount of the antifungal agent used, considering the soap use concentration and the minimum bactericidal concentration of the bacteria, the experiment As a result, the antifungal agent of the present invention should be used at least 0.1% by weight, and should not exceed 5% by weight because of poor stability over time. A clinical trial of the cosmetic soap composition of Example 1 for 20 athletes' athletes showed a cure rate of about 75%.
각질 박리/연화 효과는 고급지방산의 함량이 증가할수록 우수하게 나타났으며, 작업성을 고려하여 30 중량%를 초과하지 않아야 한다. 또한, 각 화장비누 조정물의 pH는 세정기제와 pH 조정제의 함량에 따라 pH 차이를 나타내고 있으나, 본 발명에서의 안정성 등을 고려할 때, 피부 pH와 유사하게 조절하기 위한 pH 조정액의 함량은 0.1 내지 6.0 중량%가 알맞은 것으로 나타났다.The exfoliation / softening effect is excellent as the content of higher fatty acid increases, and should not exceed 30% by weight in consideration of workability. In addition, the pH of each cosmetic soap adjuster shows a pH difference depending on the content of the cleaning agent and the pH adjuster, but considering the stability in the present invention, the content of the pH adjuster for adjusting similar to the skin pH is 0.1 to 6.0 The weight percentages were found to be appropriate.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960061013A KR100194524B1 (en) | 1996-12-02 | 1996-12-02 | Antifungal Toilet Soap Composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019960061013A KR100194524B1 (en) | 1996-12-02 | 1996-12-02 | Antifungal Toilet Soap Composition |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19980043225A KR19980043225A (en) | 1998-09-05 |
KR100194524B1 true KR100194524B1 (en) | 1999-06-15 |
Family
ID=66475119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019960061013A KR100194524B1 (en) | 1996-12-02 | 1996-12-02 | Antifungal Toilet Soap Composition |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100194524B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100469770B1 (en) * | 2002-05-20 | 2005-02-02 | 김해숙 | a soap weak acid of manufacturing method and thereof product |
-
1996
- 1996-12-02 KR KR1019960061013A patent/KR100194524B1/en not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100469770B1 (en) * | 2002-05-20 | 2005-02-02 | 김해숙 | a soap weak acid of manufacturing method and thereof product |
Also Published As
Publication number | Publication date |
---|---|
KR19980043225A (en) | 1998-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3172817A (en) | Method of deodorizing the human body and materials therefor | |
HU229230B1 (en) | Medical composition for the treatment of herpes simplex virus and other infectious diseases | |
CN105853260B (en) | A kind of diaper dermatitis frost and preparation method thereof | |
TW201416071A (en) | Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne | |
US10702491B2 (en) | Soap compositions and methods | |
KR100194524B1 (en) | Antifungal Toilet Soap Composition | |
US2254636A (en) | Medicinal product | |
US6696396B1 (en) | Therapeutic soap | |
JPH051298A (en) | Soap | |
CN109288706A (en) | Essence for being maintained at women secret | |
JPH05117140A (en) | Soap mixed with garlic essence containing vitamin b1 | |
KR20160116731A (en) | Soap Containing Rosemary Extract, and Method for Manufacturing the Same | |
KR20180001432A (en) | Moisturizing skin tissue made of natural materials | |
KR960015185B1 (en) | Disposable water tissue products containing antibiosis plant extract | |
KR19980068394A (en) | Cosmetic soap composition | |
KR101875036B1 (en) | Functional soap composition and functional soap prepared by using the same | |
US2549759A (en) | Oral composition | |
RU2110251C1 (en) | Skin protective cream "osenny" | |
JPH03157311A (en) | Cosmetic for common acne | |
KR20210026915A (en) | Cream Soap for Removing Keratin and Process forPreparation of the Same | |
JP2814229B2 (en) | Cosmetic composition | |
US4547307A (en) | Cake of soap with deodorizing action | |
JPH04334321A (en) | Preventive for dermatic inflammation | |
CN107828562A (en) | Diatom beauty soap | |
KR100315854B1 (en) | Improved antibacterial effect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19961202 |
|
PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19961202 Comment text: Request for Examination of Application |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19981126 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19990209 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 19990210 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20020121 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20030127 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20040128 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20050128 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20050128 Start annual number: 7 End annual number: 7 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20070110 |